Skip to main content
Figure 1 | Arthritis Research & Therapy

Figure 1

From: Successful immunotherapy with matrix metalloproteinase-derived peptides in adjuvant arthritis depends on the timing of peptide administration

Figure 1

Modulation of adjuvant arthritis development after nasal administration of matrix metalloproteinase (MMP) peptides prior to adjuvant arthritis. The nasal treatment was repeated four times (arrows). Data shown are mean arthritis scores ± standard error of the mean of two experiments (n = 10 rats per group). *P < 0.05 (two-tailed Mann–Whitney test) compared with the ovalbumin peptide(OVA323–339)-treated group.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us